New Key Statistics Module, Z-Score and F-Score
NAS:LSB Key Ratios
| Market Cap $ M | 61.05 |
| Enterprise Value $ M | 104.78 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 23.02 |
| Price/Book | 0.72 |
| Price/Sales | 0.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 37.00 |
| EPS (TTM) $ | -2.90 |
| Beneish M-Score | -2.49 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -3,922.20 |
| EV-to-EBIT | -4.57 |
| EV-to-EBITDA | -4.57 |
| PEG | -- |
| Shares Outstanding M | 19.08 |
| Net Margin (%) | -63.61 |
| Operating Margin % | -61.47 |
| Pre-tax Margin (%) | -63.91 |
| Quick Ratio | 0.90 |
| Current Ratio | 1.17 |
| ROA % (ttm) | -11.41 |
| ROE % (ttm) | -29.78 |
| ROIC % (ttm) | -17.37 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.00 |
LSB Number of Guru Trades
LSB Volume of Guru Trades
Gurus Latest Trades with NAS:LSB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LSB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LakeShore Biopharma Co Ltd Insider Transactions
No Available Data
News about NAS:LSB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers